Literature DB >> 17543651

Statins do not improve short-term survival in an oriental population with sepsis.

Kai-Chien Yang1, Jung-Yien Chien, Wei-Kung Tseng, Po-Ren Hsueh, Chong-Jen Yu, Chau-Chung Wu.   

Abstract

OBJECTIVES: The aim of this study was to define the effect of statin on 30-day mortality in an oriental population with sepsis.
DESIGN: We conducted a retrospective study on patients with sepsis at National Taiwan University Hospital from 2001 to 2002. The effects of statins on 30-day mortality were evaluated based on clinical settings. Log-rank test and Cox regression analysis were performed using the proportional hazards assumption.
RESULTS: A total of 763 episodes of sepsis were reviewed; 454 consecutive patients were considered eligible. Among them, 104 (22.9%) took a statin at least 30 days before admission and during sepsis course, whereas the other 350 control (77.1%) did not. There was no significant difference of 30-day sepsis-related mortality between groups (19.2% vs 18.9%, P = .952). Statin treatment was not associated with decreased mortality at 30 days (P = .853; risk ratio, 0.95; 95% confidence interval, 0.53-1.68).
CONCLUSION: Short-term, sepsis-related mortality in a septic Taiwanese population was not reduced with statin treatment in our study. We concluded that statin therapy may have little effect on the survival of sepsis in oriental people, particularly in Taiwanese.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17543651     DOI: 10.1016/j.ajem.2006.09.011

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  13 in total

1.  Effect of the use of low and high potency statins and sepsis outcomes.

Authors:  Shu-Yu Ou; Hsi Chu; Pei-Wen Chao; Shuo-Ming Ou; Yi-Jung Lee; Shu-Chen Kuo; Szu-Yuan Li; Chia-Jen Shih; Yung-Tai Chen
Journal:  Intensive Care Med       Date:  2014-08-05       Impact factor: 17.440

2.  The impact of prior long-term versus short-term statin use on the mortality of bacteraemic patients.

Authors:  W Nseir; J Mograbi; J Khateeb; O Abu-Elheja; J Bishara; B Jihad; N Assy
Journal:  Infection       Date:  2011-09-06       Impact factor: 3.553

3.  The effect of statin therapy on the incidence of infections: a retrospective cohort analysis.

Authors:  John P Magulick; Christopher R Frei; Sayed K Ali; Eric M Mortensen; Mary Jo Pugh; Christine U Oramasionwu; Kelly R Daniels; Ishak A Mansi
Journal:  Am J Med Sci       Date:  2014-03       Impact factor: 2.378

Review 4.  Statin treatment and mortality in bacterial infections--a systematic review and meta-analysis.

Authors:  Linda Björkhem-Bergman; Peter Bergman; Jan Andersson; Jonatan D Lindh
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

5.  Statins in the critically ill.

Authors:  Isabelle De Loecker; Jean-Charles Preiser
Journal:  Ann Intensive Care       Date:  2012-06-18       Impact factor: 6.925

6.  Association between statin therapy and outcomes in critically ill patients: a nested cohort study.

Authors:  Shmeylan A Al Harbi; Hani M Tamim; Yaseen M Arabi
Journal:  BMC Clin Pharmacol       Date:  2011-08-06

7.  Statins decrease mortality in Lebanese patients with sepsis: A multicenter study.

Authors:  Rola Ajrouche; Amal Al-Hajje; Nancy El-Helou; Sanaa Awada; Samar Rachidi; Salam Zein; Pascale Salameh
Journal:  Pharm Pract (Granada)       Date:  2013-06-30

8.  Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies.

Authors:  You-Dong Wan; Tong-Wen Sun; Quan-Cheng Kan; Fang-Xia Guan; Shu-Guang Zhang
Journal:  Crit Care       Date:  2014-04-11       Impact factor: 9.097

Review 9.  Systematic review and meta-analysis on the association between outpatient statins use and infectious disease-related mortality.

Authors:  Yu Ma; Xiaozhong Wen; Jing Peng; Yi Lu; Zhongmin Guo; Jiahai Lu
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

10.  Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort study.

Authors:  Luis E López-Cortés; Juan Gálvez-Acebal; María D Del Toro; Carmen Velasco; Marina de Cueto; Francisco J Caballero; Miguel A Muniain; Alvaro Pascual; Jesús Rodríguez-Baño
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.